Global equities continued to trade
higher and exhibited unusually broad
momentum, delivering 12-month highs on
several equities benchmarks up until the
middle of the month. The last two weeks,
however, saw broad deleveraging across
equities and global asset classes. Equities
saw a global sell-off in risky assets amidst
a sharp rise in US bond yields. Investors
weighed a rise in bond yields on worries
about potential inflation with oil prices at
a 12-month high and copper prices near
a decade-high. Global growth outlook
has been revised higher with economic
output expected to grow at 5-6% this
year, making it the fastest pace since the
mid-80s.
The ongoing bond bear market is
unlikely to derail global equities as yet.
By the standards of a post-recession expansion cycle, neither the direction nor the magnitude of yield
increase appears odd. The underlying drivers behind the bond yields' move matter more than their levels.
Study of US bond yield cycles depicts stocks-bonds correlation over shorter and longer timeframes. In
fact, in the last decade, whenever bond yields spiked by 50bps or more in a short period of time, equities
performed well. Generally, equity prices and P/E multiples have been positively linked to bond yields.
FOMC officials - Recovery far from central bank's goals: Minutes from the Federal Reserve's January
policy meeting indicate that the FOMC officials see the economy "far from" the central bank's goals. The
meeting summary indicates it will likely "take some time for substantial further progress to be achieved",
highlighting that the policy is unlikely to change soon. Fed Chair Powell adds that the discussion on
tapering is "premature"; indicates that "substantial further progress" towards the FOMC's goals of labour
market recovery and inflation of at least 2% is required for changing the asset purchase guidance.
Covid & Vaccines:
The progress on vaccination is being watched by markets for demand cues. The US
seems to be on track to achieve near herd immunity by mid-year and could be a turning point for global
markets. Israel has vaccinated 82% of its population with 33% of its population receiving both doses.
However, we don't yet see a sharp improvement in Google mobility for retail and recreation in Israel which
is even weaker than India's.
Outperformance in Covid containment leading to marginal hospitalization rate and death rate has probably
lowered risk perception on the street in India and hence driving retail participation. Daily new Covid-19
confirmed cases averaged ~12.5k in Feb vs. ~15k in Jan and ~25k in Dec. Although daily tests at 709k/day
in Feb were lower vs. Jan (774k/day), the positive rate increased marginally to 2.0% in end-Feb vs. 1.9%
in end-Jan.
India has administered only 14mn vaccines until 26 Feb. The current rate is way below the intended pace
of vaccination expected. The second phase starting 01 Mar will cover bulk of the 300mn targeted to be
vaccinated by Jul-Aug-21. In a bid to expand the Covid-19 vaccination drive amid fears of a second wave in
some states, the Union Cabinet will allow anyone above the age of 60 or above 45 and with comorbidities
to sign up to receive the Covid vaccines at government as well as private hospitals from 1 Mar'21.
The earnings momentum accelerated
further in 3QFY21, aided by pickup in
sales growth. Aggregate sales growth
of domestically-oriented companies has
turned positive after five consecutive
quarters of contraction, and points to a
recovering domestic demand. BSE 200 saw
second quarter of upward revision, whereas
the mid-cap index has seen 3 consecutive
quarters of upward revision in EPS estimates.
Adjusted PAT for the BSE All Cap (~840
stocks) grew a handsome 33% YoY in
3QFY21 which is the highest in nearly 4 years,
after similar strength in 2Q. Close to 70%
of this was on account of Materials/Energy
- benefitting from ongoing commodity
inflation (including oil inventory gains).
Ex-Metals, growth stands at 24% YoY.
Metals, Oil, Auto, IT and Pharma sectors are
key contributors to the earnings growth, while
BFSI, Engineering and Media disappointed.
Consensus estimates continue to be
upgraded and are now implying aggregate
PAT growth of ~30-35% YoY in FY22.